1. Home
  2. POAI vs TRAW Comparison

POAI vs TRAW Comparison

Compare POAI & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • TRAW
  • Stock Information
  • Founded
  • POAI 2002
  • TRAW 1998
  • Country
  • POAI United States
  • TRAW United States
  • Employees
  • POAI N/A
  • TRAW N/A
  • Industry
  • POAI Industrial Specialties
  • TRAW
  • Sector
  • POAI Health Care
  • TRAW
  • Exchange
  • POAI Nasdaq
  • TRAW NYSE
  • Market Cap
  • POAI 8.9M
  • TRAW 8.6M
  • IPO Year
  • POAI N/A
  • TRAW 2013
  • Fundamental
  • Price
  • POAI $0.80
  • TRAW $1.53
  • Analyst Decision
  • POAI Hold
  • TRAW
  • Analyst Count
  • POAI 1
  • TRAW 0
  • Target Price
  • POAI N/A
  • TRAW N/A
  • AVG Volume (30 Days)
  • POAI 164.4K
  • TRAW 148.9K
  • Earning Date
  • POAI 08-12-2025
  • TRAW 08-14-2025
  • Dividend Yield
  • POAI N/A
  • TRAW N/A
  • EPS Growth
  • POAI N/A
  • TRAW N/A
  • EPS
  • POAI N/A
  • TRAW N/A
  • Revenue
  • POAI $1,729,269.00
  • TRAW $227,000.00
  • Revenue This Year
  • POAI $486.27
  • TRAW $3.81
  • Revenue Next Year
  • POAI $65.50
  • TRAW $30.43
  • P/E Ratio
  • POAI N/A
  • TRAW N/A
  • Revenue Growth
  • POAI 24.17
  • TRAW 0.44
  • 52 Week Low
  • POAI $0.55
  • TRAW $0.97
  • 52 Week High
  • POAI $3.06
  • TRAW $19.44
  • Technical
  • Relative Strength Index (RSI)
  • POAI 32.97
  • TRAW 48.04
  • Support Level
  • POAI $0.73
  • TRAW $1.39
  • Resistance Level
  • POAI $0.86
  • TRAW $1.59
  • Average True Range (ATR)
  • POAI 0.05
  • TRAW 0.09
  • MACD
  • POAI -0.00
  • TRAW -0.00
  • Stochastic Oscillator
  • POAI 30.59
  • TRAW 33.75

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Share on Social Networks: